Dr Alvin Low Wei Xiang

MBBS (S'pore),MRCS (Edin),FAMS (S'pore)

Consultant

Profile

Dr Alvin Low is a Consultant in the Urology Department, Sengkang General Hospital. He graduated from the Yong Loo Lin School of Medcine, National University of Singapore with a Bachelor of Medicine and Surgery (MBBS) in 2011. He completed his intercollegiate Membership of the Royal College of Surgeons (MRCS, Edinburgh) in 2013 followed by the Singhealth Urology Residency training and joined the Academy of Medicine, Singapore as a Fellow.

Education

MBBS (Singapore): Yong Loo Lin School of Medicine, National University of Singapore
MRCS (Edinburgh): United Kingdom
FAMS (Singapore)

Professional Appointments and Committee Memberships

Clinical instructor, Duke-NUS
Adjunct Research Fellow, Duke-NUS
Clinical Lecturer, Yong Loo Lin School of Medicine, NUS
Clinical Teacher, Lee Kong Chian School of Medicine, NTU
Member, Singapore Urological Association
Member, European Association of Urology
Member, American Urology Association
Member, Royal College of Surgeons (Edinburgh)

Awards

Surgery ACP Seed Grant, 2018
SGH Research Grant, 2019
Service with a Heart award, 2019
Quality Improvement project - Significant Impact Award, 2020
Healthcare Product Design Award (SUTD), 2022

Research Interests

Publications and Research Trials

Oncological outcomes following robotic-assisted radical prostatectomy in a multiracial Asian population. Alvin LWX, Gee SH, Hong HH, Christopher CW, Henry HS, Weber LK, Hoon TP, Shiong LL. J Robot Surg. 2015 Sep;9(3):201-9.
Ambulatory robot-assisted laparoscopic radical prostatectomy with extended recovery by total extraperitoneal approach. Alvin LWX, Chen K, Tan YG, Ng TK, Yuen JSP. Int J Urol. 2021 May
Sandwiched posterior-anterior reconstructed tissue-glued anastomosis (SPARTAN) in RARP: A consistently reproducible urethro-vesical anastomosis for early catheter removal and continence recovery. Alvin LWX, Tze K. Ng, John S.P. Yuen. Urology Video Journal, Volume 4, 2019
Biomarkers for Precision Urothelial Carcinoma Diagnosis: Current Approaches and the Application of Single-Cell Technologies. Hong M, He G, Goh S, Alvin LWX, Tay KJ, Lim TKH, Yeong J, Khor LY, Lim TS. Cancers (Basel). 2021 Jan 12
Immunological Hallmarks for Clinical Response to BCG in Bladder Cancer. Front Lim CJ, Nguyen PHD, Wasser M, Kumar P, Lee YH, Nasir NJM, Chua C, Lai L, Hazirah SN, Loh JJH, Khor LY, Yeong J, Lim TKH, Alvin LWX, Albani S, Chong TW, Chew V. Immunol. 2021 Jan 29

Research Trials

The Sonic Hedgehog link; histopathology and protein analysis of stented and non-stented paired porcine ureter
The Urinary Unknown; uncovering unknown urine/blood biomarkers of ureteric presenting and dilatation in pig to humans.
A novel technique to improve diagnostic accuracy of urine cytology and biomarkers in bladder cancer.
Investigating the role of PRL-3 as urinary biomarker and therapeutic target in kidney (RCC) and bladder cancers.